结核分枝杆菌潜伏感染的预防性治疗研究进展

师 晓晶, 张 少芳, 眭 晓哲
石家庄科技职业学院

摘要


结核分枝杆菌潜伏感染为结核病提供源源不断的“患者库”，对其采取预防性治疗是终结结核流行的三项重要举措之一。本文综述了国内外不同LTBI者人群的预防性治疗依从性、安全性和有效性等研究进展，以期为快速推进预防性治疗工作提供参考价值。

关键词


结核分枝杆菌；潜伏感染；预防性治疗；综述

全文:

PDF


参考


[1]World Health Organization. Global tuberculosis report 2024[R]. Geneva: WHO, 2024.

[2]Thindwa D, MacPherson P, Choko A T, et al. Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi[J]. Int J Tuberc Lung Dis, 2018,22(3):273-279.

[3]White H A, Okhai H, Sahota A, et al. Latent tuberculosis screening and treatment in HIV: highly acceptable in a prospective cohort study[J]. ERJ Open Research, 2022,8(2): 00442 - 2021.

[4]Manisha H, Amani W, Garrib A, et al. IPT coverage and determinants of care coverage in Tanzania[J]. Public Health Action, 2022,12(3):141-146.

[5]洪可,张定宇,阮连国.武汉市HIV/AIDS患者潜伏性结核感染筛查及预防效果[J].传染病信息,2021,34 (05):422-425.

[6]Bonnet M, Vasiliu A, Tchounga B K, et al. Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial[J]. Lancet Glob Health, 2023,11(12):e1911-e1921.

[7]Felisia F, Triasih R, Nababan B W Y, et al. High Tuberculosis Preventive Treatment Uptake and Completion Rates Using a Person-Centered Approach among Tuberculosis Household Contact in Yogyakarta[J]. Trop Med Infect Dis, 2023,8(12):520.

[8]加依那提·金格斯,王新旗,刘年强,等.387名结核分枝杆菌潜伏感染者预防性治疗服药完成情况及影响因素分析[J].中国防痨杂志,2024,46(12):1496-1503.

[9]王展,李忠奇,丁晓艳,等.江苏省学生结核潜伏感染者预防性治疗意愿现状及其影响因素[J].中国热带医学,2024,24(03):244-251.

[10]Yuan Y M, Jin J, Bi X L, et al. Factors associated with refusal of preventive therapy after initial willingness to accept treatment among college students with latent tuberculosis infection in Shandong, China[J]. BMC Infect Dis,2023:38.

[11]Usdin M, Dedicoat M, Gajraj R, et al. Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis[J]. Int J Tuberc Lung Dis, 2017,21(2):175-180.

[12]Zakaria W M Z, Mansor Z. Intention to receive Latent Tuberculosis Infection (LTBI) treatment and its associated factors among healthcare workers in a Malaysian teaching university hospital[J]. PLoS One, 2024,19(7):e0307199.

[13]Bar-Meir M, Pariente G, Romem A, et al. Identifying factors affecting latent tuberculosis treatment acceptance among healthcare workers: a retrospective analysis in a tertiary care centre[J]. BMJ Open, 2021,11(9):e047444.

[14]Han S S, Lee S J, Yim J J, et al. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis[J]. PLoS One, 2019,14(9):e0222810.


Refbacks

  • 当前没有refback。